ID   YMB-S
AC   CVCL_D103
DR   cancercelllines; CVCL_D103
DR   Wikidata; Q54995449
RX   PubMed=8144402;
RX   PubMed=11179484;
CC   Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2814 ! YMB-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 19
//
RX   PubMed=8144402; DOI=10.1111/j.1349-7006.1994.tb02084.x;
RA   Hamada H., Kohno N., Hiwada K.;
RT   "A new serum tumor marker, CAM 123-6, highly specific to pulmonary
RT   adenocarcinoma.";
RL   Jpn. J. Cancer Res. 85:211-219(1994).
//
RX   PubMed=11179484; DOI=10.3892/ijo.18.3.541;
RA   Yang S.-Z., Kohno N., Yokoyama A., Kondo K., Hamada H., Hiwada K.;
RT   "Decreased E-cadherin augments beta-catenin nuclear localization:
RT   studies in breast cancer cell lines.";
RL   Int. J. Oncol. 18:541-548(2001).
//